Overview
- Description
The company is a spin-off from the University of Valencia developing advanced RNA treatments for genetic diseases, with a focus on myotonic dystrophy type 1.
- Website
- Country
- Spain
- Sector
- Health Biotechnology
Engage with ARTHEX BIOTECH S.L.*
*By clicking here you will be leaving the official EIC website and you will be directed to the Dealroom.co domain, an official EISMEA contractor for the EIC investor matchmaking platform.